Locally Performed HRD Testing for Ovarian Cancer? Yes, We Can!

Locally Performed HRD Testing for Ovarian Cancer? Yes, We Can!

Assessment of HRD status is now essential for ovarian cancer patient management. A relevant percentage of high-grade serous carcinoma (HGSC) is characterized by HRD, which is caused by genetic alterations in the homologous recombination repair (HRR) pathway. Recent trials have shown that not only pa...

Full description

Bibliographic Details
Main Authors: Gilda Magliacane, Emanuela Brunetto, Silvia Calzavara, Alice Bergamini, Giovanni Battista Pipitone, Giovanna Marra, Miriam Redegalli, Greta Grassini, Emanuela Rabaiotti, Gianluca Taccagni, Lorenza Pecciarini, Paola Carrera, Giorgia Mangili, Claudio Doglioni, Maria Giulia Cangi
Format: Article
Language:English
Published: MDPI AG 2022-12-01
Series:Cancers
Subjects:
BRCA
HRD
HRR
NGS
molecular testing
ovarian cancer
Online Access:https://www.mdpi.com/2072-6694/15/1/43

Internet

https://www.mdpi.com/2072-6694/15/1/43

Similar Items